533212 Stock Overview
Engages in manufacture and sale of unfinished ophthalmic lenses in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
GKB Ophthalmics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹97.94 |
| 52 Week High | ₹136.40 |
| 52 Week Low | ₹74.10 |
| Beta | 0.45 |
| 11 Month Change | -6.72% |
| 3 Month Change | -17.49% |
| 1 Year Change | 2.85% |
| 33 Year Change | 30.76% |
| 5 Year Change | 120.09% |
| Change since IPO | 38.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| 533212 | IN Medical Equipment | IN Market | |
|---|---|---|---|
| 7D | 1.3% | -8.0% | 2.0% |
| 1Y | 2.8% | 64.8% | 26.6% |
Return vs Industry: 533212 underperformed the Indian Medical Equipment industry which returned 64.8% over the past year.
Return vs Market: 533212 underperformed the Indian Market which returned 26.6% over the past year.
Price Volatility
| 533212 volatility | |
|---|---|
| 533212 Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 533212 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 533212's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 162 | Krishna Gupta | gkb.net |
GKB Ophthalmics Limited engages in manufacture and sale of unfinished ophthalmic lenses in India and internationally. The company provides semi-finished organic lenses, which includes single vision, bifocal, progressive, and aspheric. GKB Ophthalmics Limited was incorporated in 1981 and is based in Mapusa, India.
GKB Ophthalmics Limited Fundamentals Summary
| 533212 fundamental statistics | |
|---|---|
| Market cap | ₹487.83m |
| Earnings (TTM) | -₹36.35m |
| Revenue (TTM) | ₹977.56m |
0.5x
P/S Ratio-13.6x
P/E RatioIs 533212 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 533212 income statement (TTM) | |
|---|---|
| Revenue | ₹977.56m |
| Cost of Revenue | ₹670.55m |
| Gross Profit | ₹307.01m |
| Other Expenses | ₹343.36m |
| Earnings | -₹36.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.21 |
| Gross Margin | 31.41% |
| Net Profit Margin | -3.72% |
| Debt/Equity Ratio | 19.6% |
How did 533212 perform over the long term?
See historical performance and comparison